These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 11840171)

  • 1. Apoptosis coincident with the differentiation of skeletal myoblasts is delayed by caspase 3 inhibition and abrogated by MEK-independent constitutive Ras signaling.
    Dee K; Freer M; Mei Y; Weyman CM
    Cell Death Differ; 2002 Feb; 9(2):209-18. PubMed ID: 11840171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active Ras-induced effects on skeletal myoblast differentiation and apoptosis are independent of constitutive PI3-kinase activity.
    Karasarides M; Dee K; Schulman D; Wolfman A; Weyman CM
    Cell Biol Int; 2006 Apr; 30(4):308-18. PubMed ID: 16503174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raf-induced effects on the differentiation and apoptosis of skeletal myoblasts are determined by the level of Raf signaling: abrogation of apoptosis by Raf is downstream of caspase 3 activation.
    DeChant AK; Dee K; Weyman CM
    Oncogene; 2002 Aug; 21(34):5268-79. PubMed ID: 12149648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct signaling pathways regulate transformation and inhibition of skeletal muscle differentiation by oncogenic Ras.
    Weyman CM; Ramocki MB; Taparowsky EJ; Wolfman A
    Oncogene; 1997 Feb; 14(6):697-704. PubMed ID: 9038377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential signaling through NFkappaB does not ameliorate skeletal myoblast apoptosis during differentiation.
    Dee K; DeChant A; Weyman CM
    FEBS Lett; 2003 Jun; 545(2-3):246-52. PubMed ID: 12804784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitogen-activated protein kinase kinase (MEK) activity is required for inhibition of skeletal muscle differentiation by insulin-like growth factor 1 or fibroblast growth factor 2.
    Weyman CM; Wolfman A
    Endocrinology; 1998 Apr; 139(4):1794-800. PubMed ID: 9528964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic Ras-induced secretion of a novel inhibitor of skeletal myoblast differentiation.
    Weyman CM; Wolfman A
    Oncogene; 1997 Nov; 15(21):2521-8. PubMed ID: 9399640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling through the TRAIL receptor DR5/FADD pathway plays a role in the apoptosis associated with skeletal myoblast differentiation.
    O'Flaherty J; Mei Y; Freer M; Weyman CM
    Apoptosis; 2006 Dec; 11(12):2103-13. PubMed ID: 17041756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of the pro-apoptotic Bcl2 family member PUMA is required for mitochondrial release of cytochrome C and the apoptosis associated with skeletal myoblast differentiation.
    Shaltouki A; Freer M; Mei Y; Weyman CM
    Apoptosis; 2007 Dec; 12(12):2143-54. PubMed ID: 17879164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of farnesyl protein transferase and MEK1,2 induce apoptosis in fibroblasts transformed with farnesylated but not geranylgeranylated H-Ras.
    Brassard DL; English JM; Malkowski M; Kirschmeier P; Nagabhushan TL; Bishop WR
    Exp Cell Res; 2002 Feb; 273(2):138-46. PubMed ID: 11822869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of myogenesis by the H-ras oncogene: implication of a role for protein kinase C.
    Vaidya TB; Weyman CM; Teegarden D; Ashendel CL; Taparowsky EJ
    J Cell Biol; 1991 Aug; 114(4):809-20. PubMed ID: 1714463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ERK1/2 is required for myoblast proliferation but is dispensable for muscle gene expression and cell fusion.
    Jones NC; Fedorov YV; Rosenthal RS; Olwin BB
    J Cell Physiol; 2001 Jan; 186(1):104-15. PubMed ID: 11147804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S100B stimulates myoblast proliferation and inhibits myoblast differentiation by independently stimulating ERK1/2 and inhibiting p38 MAPK.
    Riuzzi F; Sorci G; Donato R
    J Cell Physiol; 2006 May; 207(2):461-70. PubMed ID: 16419039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of erythroid differentiation by inhibition of Ras/ERK pathway in a friend murine leukemia cell line.
    Matsuzaki T; Aisaki Ki; Yamamura Y; Noda M; Ikawa Y
    Oncogene; 2000 Mar; 19(12):1500-8. PubMed ID: 10734309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caspase inhibitors induce a switch from apoptotic to proinflammatory signaling in CD95-stimulated T lymphocytes.
    Scheller C; Sopper S; Ehrhardt C; Flory E; Chen P; Koutsilieri E; Ludwig S; ter Meulen V; Jassoy C
    Eur J Immunol; 2002 Sep; 32(9):2471-80. PubMed ID: 12207331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raf-1 activation stimulates proliferation and inhibits IGF-stimulated differentiation in L6A1 myoblasts.
    Samuel DS; Ewton DZ; Coolican SA; Petley TD; McWade FJ; Florini JR
    Horm Metab Res; 1999; 31(2-3):55-64. PubMed ID: 10226782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor (IGF)-binding protein-related protein-1: an autocrine/paracrine factor that inhibits skeletal myoblast differentiation but permits proliferation in response to IGF.
    Haugk KL; Wilson HM; Swisshelm K; Quinn LS
    Endocrinology; 2000 Jan; 141(1):100-10. PubMed ID: 10614628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular signal-regulated kinase-1 and -2 respond differently to mitogenic and differentiative signaling pathways in myoblasts.
    Sarbassov DD; Jones LG; Peterson CA
    Mol Endocrinol; 1997 Dec; 11(13):2038-47. PubMed ID: 9415407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear exclusion of forkhead box O and Elk1 and activation of nuclear factor-kappaB are required for C2C12-RasV12C40 myoblast differentiation.
    De Alvaro C; Nieto-Vazquez I; Rojas JM; Lorenzo M
    Endocrinology; 2008 Feb; 149(2):793-801. PubMed ID: 17962350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive regulation of skeletal myogenesis by R-Ras.
    Suzuki J; Kaziro Y; Koide H
    Oncogene; 2000 Feb; 19(9):1138-46. PubMed ID: 10713701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.